[Federal Register: November 12, 2002 (Volume 67, Number 218)]
[Notices]               
[Page 68688]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr12no02-113]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated April 11, 2002, and published in the Federal 
Register on April 26, 2002 (67 FR 20828), Noramco of Delaware, Inc., 
Division of McNeilab, Inc., which has changed its name to Noramco of 
Delaware, Inc., Division of Ortho-McNeil, Inc., 500 Old Swedes Landing 
Road, Wilmington, Delaware 19801, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine (9050)..............................  II
Oxycodone (9143)............................  II
Hydrocodone (9193)..........................  II
Morphine (9300).............................  II
Thebaine (9333).............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
distribution to its customers as bulk product.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Noramco of Delaware, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Noramco of Delaware, 
Inc. on a regular basis to ensure that the company's continued 
registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, audits of the company's records, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed above 
is granted.

    Dated: October 21, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-28656 Filed 11-8-02; 8:45 am]

BILLING CODE 4410-09-M